Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: Recommendations from the Prostate-Specific Antigen Working Group

Howard I. Scher, Mario Eisenberger, Anthony V. D'Amico, Susan Halabi, Eric J. Small, Michael Morris, Michael W. Kattan, Mack Roach, Philip Kantoff, Kenneth J. Pienta, Michael A. Carducci, David Agus, Susan F. Slovin, Glenn Heller, William Kevin Kelly, Paul H. Lange, Daniel Petrylak, William Berg, Celestra Higano, George WildingJudd W. Moul, Alan N. Partin, Christopher Logothetis, Howard R. Soule

Research output: Contribution to journalReview articlepeer-review

Fingerprint

Dive into the research topics of 'Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: Recommendations from the Prostate-Specific Antigen Working Group'. Together they form a unique fingerprint.

Medicine & Life Sciences